Research on Plasma for Covid-19 Drugs Turns Out to be Less Effective

LUMAJANG NEWS – Recently, many studies have been conducted to tackle Covid, one of which is plasma.

Quoted KabarLumajang.com from Aljazeera 23 October 2020, plasma taken from the blood of recovered Covid-19 patients and given to sick people with the disease does not reduce their chances of becoming seriously ill or dying, according to new research in India.

The study involved more than 400 people who were in hospital with Covid-19, studying it plasma convalescent (plasma patients recovered) to treat patients with minor illnesses.

The results, published in the medical journal BMJ on Friday, concluded that “plasma convalescent shows limited effectiveness “.

Also Read: Tsunami 524 AD Predicted to Happen in Alaska, the results of his research make goosebumps, this is why

The discovery from one of the first clinical trials investigating its efficacy plasma convalesent is a treatment idea proposed by US President Donald Trump since August as a “historic breakthrough”.

The United States and India, which are battling the world’s worst covid-19 outbreak, both have plasma convalescent for emergency use.

Countries like England have already collected donations plasma so that it can be used immediately if proven to be mamu drug effective.

“The trials have shown little effect at the rate at which patients can escape the virus, but this is not enough to improve their recovery from the disease,” said Simon Clarke, a cellular microbiologist at the University of Reading.

– .